The first meeting of the AMCHAM’s Pharmaceutical Committee was held virtually on August 26th under the leadership of Mr. Umang Chaturvedi, Chairman – Pharmaceutical Committee, AMCHAM and Head of Policy & International Affairs, Mylan and Ms. Jyotsna Ghosal, Co-Chairperson – Pharmaceutical Committee, AMCHAM and Executive Director – Corporate Communications, Johnson and Johnson. Senior healthcare experts from Baxter, Eli Lilly, Honeywell India, Corning Technologies, IFF, Deloitte, Par Formulations, Dua Associates, APCO Worldwide and Paraxel participated. It was decided that going forward, the committee would focus on select policy and regulatory issues. Some of the priority issues highlighted by members included market access issues – PPO and TMR, regulatory barriers and IP burden. In addition, the committee would be strongly taking up policy advocacy with relevant stakeholders and have engagements with state governments.
By joining AMCHAM India, you become part of an active and dynamic Apex Chamber of U.S. Industry in India with a membership base of more than 400 American companies in India. AMCHAM is an important voice for policy advocacy, a critical source for business intelligence, a vibrant platform for networking and expanding your business.